December 13, 2024 00:59 (IST)
Bavarian Nordic monkeypox vaccine gets EU approval
Jul 25, 2022, at 06:51 pm
Copenhagen: Bavarian Nordic announced on Monday that the European Commission (EC) has extended the marketing authorization for the Company’s smallpox vaccine, IMVANEX to include protection from monkeypox and disease caused by vaccinia virus.
Latest Headlines
Bavarian Nordic monkeypox vaccine gets EU approval
Mon, Jul 25 2022